Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 658 | 28,073 | 1,482 | 1,357 | 6,501 |
| Gross Profit | 658 | 28,073 | 1,482 | 1,357 | 6,501 |
| Operating Expenses | 22,008 | 22,371 | 26,628 | 29,942 | 32,090 |
| Operating Income | -21,350 | 5,702 | -25,146 | -28,585 | -25,589 |
| Other Income | 31 | 6 | 9 | -1,535 | 3,940 |
| Pre-tax Income | -21,319 | 5,708 | -25,137 | -30,120 | -21,649 |
| Net Income Continuous | -21,319 | 5,708 | -25,137 | -30,120 | -21,649 |
| Net Income | $-21,319 | $5,708 | $-25,137 | $-30,120 | $-21,649 |
| EPS Basic Total Ops | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
| EPS Basic Continuous Ops | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
| EPS Diluted Total Ops | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
| EPS Diluted Continuous Ops | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
| EBITDA(a) | $-18,517 | $7,209 | $-23,811 | $-27,289 | $-24,213 |